The European Medicines Agency (EMA) has recently approved Sirturo (bedaquiline) for conditional use in the European Union for adults suffering from pulmonary MDR-TB.
The press release from Multimedia News Release can be found at:
http://www.multivu.com/mnr/65014-sirturo-treatment-multi-drug-resistant-tuberculosis
Back in December 2012, the same drug was approved by the US Food and Drug Administration. The blog post highlighting that announcement can be found at: